Surgical Outcome of Fungating Sarcomas.
Keywords:Fungating, Sarcomas, Tumour.
Objective: To determine the surgical outcomes of fungating sarcomas.
Methods: This descriptive study was conducted in Orthopaedics and Spine Unit Hayatabad Medical Complex Peshawar and Rehman Medical Institute Hayatabad Peshawar from 2nd January 2016 to 2nd December 2020.Patients of both gender and all ages with fungating sarcoma of bony or soft tissue origin meeting the inclusion criteria were included in this study and operated. Analysis of patient’s characteristics, tumour type, surgery, complications, recurrence and mortality was noted in each case.
Results: We operated 16 patients of fungating sarcomas. The mean age was 30.5±17 years. All patients were male. Soft tissue sarcoma was present in 8(50%) and bony in 8(50%). Upper limb sarcoma was noted in 9(56.25%),lower limb in 6(37.5%) and neck in 1(6.25%) patient. Resection of soft tissue sarcomas followed by reconstruction was performed in 4( 8.69%) patients. Forequarter amputation was performed in 6(37.5%) cases, 3(18.75%) patients underwent hip disarticulation and 3(18.75%) patients had transfemoral amputations. Local complication was noted in 4(25%) patients with 3(18.75%) had wound dehiscence and 1(6.25%) had local recurrence at three months. Post surgery the mean survival time was 8 months and at 2 years follow up only 4(25%) patients were alive.
Conclusion: Poor post operative prognosis and high mortality was noted for fungating sarcoma in our series. We however advise surgery for fungating sarcomas to alleviate symptoms and misery of these patients and improve their quality of life.
Parry M, Evans S, Sugath S, Wafa H, Jeys L, Grimer R. Fungation in soft tissue sarcomas is associated with poor survival. Int Orthop 2017;41(12):2613-2618.
Pisters PW, Leung DH, Woodruff J, Shi W, Brennan MF. Analysis of prognostic factors in 1,041 patients with localised soft tissue sarcomas of the extremeties. J Clin Oncol 1996; 14(5):1679-1689.
Alexander S. Malignant fungating wounds: epidemiology, aetiology, presentation and assessment. J Wound care 2009; 18:273-4.276-278.
Carville K. Wound care manual 2005; Vol 5, Fifth edition, Silver chain foundation. pp 311-317.
Potter BK, Adams SC, Qadir R, Pitcher JD, Temple HT. Fungating soft tissue sarcomas. Treatment implications and prognostic importance of malignant ulceration. J bone Joint Surg Am 2009; 91-A(3):567-574.
Akbarnia BA, Wirth CR, Colman N. Fibrosarcoma arising from chronic osteomyelitis. Case report and review of the literature. J Bone Joint Surg Am 1976; 58-A(1):123-125.
McGrory JE, Pritchard DJ, Unni KK, Ilstrup D, Rowland CM. Malignant lesions arising in chronic osteomyelitis. Clin Orthop Relat Res 1999; 362:181.
Siddiqui Y S, Sherwani M, Khan A Q, Zahid M, Abbas M, Asif N. Neglected orthopedic oncology - Causes, epidemiology and challenges for management in developing countries. Indian J Cancer 2015; 52:325-329.
Grimer R, Judson I, Peake D, Seddon B. Guidelines for the Management of Soft Tissue Sarcomas.Sarcoma 2010. doi: 10.1155/2010/506182.
Gerrand, C, Athanasou N, Brennan B, Grimer R, Ian Judson I, Morland B, et al. UK guidelines for the management of bone sarcomas. Clin Sarcoma Re 2016 ;Doi: https://doi.org/10.1186/s13569-016-0047-1.
Casali PG, Jost L, Sleijfer S, Verweij J, Blay JY. Soft tissue sarcomas: ESMO clinical recommendations for diagnosis, treatment and follow-up. Annals of Oncology 2019; 19(2):89-93.
Smith GM, Johnson GD, Grimer RJ, Wilson S. Trends in presentation of bone and soft tissue sarcomas over 25 years: little evidence of earlier diagnosis. Ann R Coll Surg Engl 2011; 93(7):542-547.
Grimer RJ. Size matters for sarcomas. Ann R Coll Surg Engl. 2006;88(6):519-524.
Singer S, Corson JM, Gonin R, Labow B, Eberlein TJ. Prognostic factors predictive of survival and local recurrence for extremity soft tissue sarcoma. Ann Surg 1994; 219(2):165-173.
Yang JC, Chang AE, Baker AR, Sindelar WF, Danforth DN, Topalian SL, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 1998; 16(1):197-203.
Karakousis CP, Proimakis C, Walsh DL. Primary soft tissue sarcoma of the extremities in adults. Br J Surg 1995; 82(9):1208–1212
Wilson AN, Davis A, Bell RS, O'Sullivan B, Catton C, Madadi F, et al. Local control of soft tissue sarcoma of the extremity: the experience of a multidisciplinary sarcoma group with definitive surgery and radiotherapy. Eur J Cancer 1994; 30A(6):746-751.
Malawer MM, Buch RG, Thompson WE, Sugarbaker PH. Major amputations done with palliative intent in the treatment of local bony complications associated with advanced cancer. J Surg Oncol 1991; 47:121-30.
Merimsky O, Kollender Y, Inbar M, Lev-Chelouche D, Gutman M, Issakov J, et al. Is forequarter amputation justified for palliation of intractable cancer symptoms? Oncology 2001; 60:55-59.
Wittig JC, Bickels J, Kollender Y, Miller I,Malawer MM. Palliative forequarter amputation for metastatic carcinoma to the shoulder girdle region: Indications, preoperative evaluation, surgical technique, and results. J Surg Oncol 2001; 77:105-113.
Parsons CM, Pimiento JM, Cheong D, Marzban SS, Gonzalez RJ, Johnson D, et al. The role of radical amputations for extremity tumors: a single institution experience and review of the literature. J Surg Oncol 2012;105(2):149-55.
Merimsky O, Kollender Y, Inbar M, Chaitchik, Meller I. Palliative major amputation and quality of life in cancer patients. Acta Oncol. 1997;36(2):151-157.
Grimer RJ, Briggs TWR. Earlier diagnosis of bone and soft tissue tumours. J Bone Joint Surg Br 2010; 92-B(11):1489-1492.